You are here: Home » Markets » News
Business Standard

Valiant Organics zooms 17%, hits record high as board to mull bonus issue

The company said it will consider bonus issue and interim dividend during its board meeting on November 13

Topics
Valiant Organics | Buzzing stocks | Markets

SI Reporter  |  Mumbai 

HNI, high net worth individuals, rich, billionaires, millionaires, investors, investment, stocks, valuations, brokers, earnings
Valiant Organics is a chemical company with key focus on manufacturing and supplying of specialty chemicals in India and abroad

Shares of moved higher by 17 per cent to hit a record high of Rs 3,851 on the BSE on Thursday after the company said its board will consider bonus issue and interim dividend on November 13. The stock surpassed its previous high of Rs 3,750, touched on October 12, 2020.

"The meeting of the board of directors of the Company is scheduled on November 13, 2020, to consider financial results of the Company for the half year ended on September 30, 2020," said in a regulatory filing today.

It added the board will also consider the proposal for issuance of bonus shares to the shareholders of the company (equity shares and optionally convertible preference shares) and to declare interim dividend for the financial year 2020-21, if any.

is a chemical company with key focus on manufacturing and supplying of specialty chemicals in India and abroad. The products find applications in a number of industries such as agro-chemical, pharmaceutical, rubber, and dyes and pigment industries, and veterinary drugs manufacturing.

"We are well prepared to take advantage of the growing opportunities in specialty chemicals, as India's specialty chemicals market sets itself on the growth path for the coming years, and with a rising need for specialty chemicals in the end-use domestic As we add specialty chemicals to our portfolio and continually update our product mix, we remain well positioned to capture this growth and become a leading specialty chemicals player in India, delivering sustainable stakeholder growth," Valiant Organics said in 2019-20 annual report.

With the current ongoing projects and expansion plans, revenue share from Pharmaceuticals (API) is likely to increase in the coming fiscal. The Company said it hopes to be operating at near normal levels from the second quarter of FY 2020-21. It is experiencing a gradual pick-up in demand for its products post commencement of operations.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, November 05 2020. 14:53 IST
RECOMMENDED FOR YOU
.